INTRODUCTION
============

microRNAs (miRNAs) are endogenous non-coding single-stranded RNA molecules that play important roles in eukaryotic gene expression through posttranscriptional regulation ([@B6]). It mainly binds to the 3′-untranslated region (3′-UTR) of messenger RNAs (mRNAs) from target protein-coding genes and leads to gene silencing by mRNA cleavage, translational repression and deadenylation ([@B41]). Functional studies indicate that miRNA plays a significant role in a broad range of cellular and developmental processes such as stem cell maintenance ([@B39]), differentiation ([@B15]; [@B59]), cell cycle ([@B36]), development ([@B38]), learning and memory formation ([@B31]), energy metabolism ([@B32]), and immune responses ([@B89]). miRNAs can only function as part of ribonucleoprotein (RNP) complex called RNA induced silencing complex (RISC), which contains various proteins such as argonautes, fragile X mental retardation protein (FMRP), Dicer and monkey leukemia virus 10 (MOV10; [@B44]; [@B51]). Like miRNAs, RISC plays a crucial role in many cellular processes during development and cellular differentiation. For example, deletion of core protein of RISC, Ago2 leads to embryonic lethality in mouse ([@B56]). Similarly, ablation of *Dicer* or DiGeorge syndrome critical region gene 8 (*DGCR8*) also causes developmental arrest in murine embryonic stem cells ([@B10]; [@B83]). Although it is widely accepted that miRNAs are important for nervous system development and function, a little is known about the role of individual miRNAs in neuron at the moment.

BIOGENESIS AND DECAY OF miRNAs
==============================

The majority of characterized miRNAs are transcribed by RNA polymerase II from their own independent genes or introns of protein-coding genes ([@B47]). The primary transcript (pri-miRNAs) of miRNA is specifically recognized by microprocessor complex. The microprocessor complex is composed by nuclear ribonuclease III, Drosha, and its binding partner, DGCR8. In this complex, a double stranded RNA-binding protein, DGCR8 recognizes the stem-loop structure in pri-miRNA and Drosha cleaves the pri-miRNA into a \~70-nucleotide precursor form (pre-miRNA). Afterward, pre-miRNA is translocated to the cytoplasm by exportin 5 through the nuclear pore complex in a Ran guanosine triphosphate (RanGTP)-dependent process. In the cytoplasm, second RNaseIII containing protein complex cleaves pre-miRNA to \~20 bp miRNA/miRNA\* duplex. This complex is composed of Dicer (RNaseIII), transactivation response RNA binding protein (TRBP), and protein activator of the interferon-induced protein kinase (PACT). One strand of the miRNA duplex is incorporated into the RISC as a mature miRNA (guide strand/miRNA), whereas the other strand (passenger strand/miRNA^\*^) is degraded ([@B46]).

miRNA can only function in the RISC. The functional core proteins of RISC are mainly composed of Argonaute families (Ago1-4) and glycin-tryptophan protein of 182 kDa (GW182). In RISC, only Agonaute proteins show endonuclease enzymatic activity, which is responsible for mRNA silencing ([@B41]). GW182 proteins are also essential for the RISC function ([@B26]). It inhibits binding of poly-A binding protein (PABPC) to poly-A tail and induces deadenylation, decapping, and decay of mRNAs ([@B92]). Additional proteins associated with RISC have been identified such as FMRP, MOV10, and Hu-Antigen R (HuR; [@B51]).

Expression of miRNAs seems to be tightly regulated by sophisticated mechanisms from the biogenesis to decay. Although it is not yet fully understood, the stability of mature miRNA is controlled by endogenous factors such as miRNA degrading enzymes and occupancy by target mRNAs. In animal cells, miRNA decay is carried out by the 5′-to-3′ exoribonuclease 1 and 2 (XRN1 and XRN2; [@B5]). Interestingly, it seems that binding to their target mRNAs can increase or decrease stability of miRNAs ([@B13]; [@B42]). Additionally, environmental factors such as growth factors, cell cycle, and neuronal activity can influence on stability of miRNAs ([@B71]).

miRNA IN MOTOR NEURONS
======================

Numerous studies have shown that miRNAs play an important role for nervous system development ([@B17]; [@B2]; [@B95]). Disturbing miRNA biogenesis pathway by deleting Dicer1 from spinal motor neurons in mouse caused spinal muscular atrophy (SMA) like phenotype ([@B35]). More specifically, modifying miR-9 expression in developing motor neurons alters motor neuron subtype specification as well as columnar development of spinal cords in chick embryos ([@B62]). In this model, miR-9 regulates expression of transcription factor, forkhead box P1 (*FoxP1*), which plays a crucial role for development and neuronal subtype differentiation in spinal cord ([@B63]). Another interesting miRNA in motor neuron is miR-17-3p. This miRNA directly regulates mRNA translation of oligodendrocyte transcription factor 2 (*Olig2*), which is an important transcription factor for spinal motor neuron differentiation. The expression of miR-17-3p is repressed by sonic hedgehog (Shh), which results in elevated expression of *Olig2*. Thus, high amount of Shh will direct neuronal progenitors to differentiate toward motor neurons and decrease interneuron population. Additionally, deletion of miR-17\~92 cluster from mouse embryos suggests that this cluster regulates differentiation of interneurons as well as motor neurons in early spinal cord development ([@B16]). **Table [1](#T1){ref-type="table"}** summarizes motor neuron related miRNAs discussed in this review.

###### 

The list of motor neuron related miRNAs discussed in this review.

  miRNA                           Findings                                                                                                                       Target genes       Related disease/model organism                                       Reference
  ------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ------------------ -------------------------------------------------------------------- ----------------
  miR-8                           Presynaptic bouton formation/synaptic growth                                                                                   Lar and Wg         Fruit fly                                                            [@B61]
  miR-9                           Motor neuron subtype specification/spinal cord development                                                                     FoxP1              Chick                                                                [@B2],[@B3])
                                  Dysregulated expression in motor neurons differentiated from embryonic stem cells                                                                 SMA/mouse                                                            [@B35]
                                  Expression is elevated in induced stem cell derived neurons from ALS patient                                                                      ALS/cell line (Human)                                                [@B93]
                                  Axon growth                                                                                                                    MAP1B              Mouse                                                                [@B20]
  miR-17-3p                       Spinal motor neuron differentiation                                                                                            Olig2              Mouse                                                                [@B16]
  miR17\~92 cluster               Differentiation of interneuron and motor neurons                                                                                                  Mouse                                                                [@B16]
  miR-21                          Axonal regeneration                                                                                                            Sprouty2           Mouse                                                                [@B78]
                                  Spinal cord injury                                                                                                             PTEN and FasL      Rat                                                                  [@B40]
  miR-23a, miR-29b, and miR-455   Expression is increased in skeletal muscle from ALS patients and it may cause dysregulation in mitochondrial gene expression   PGC1-α (miR-23a)   ALS/mouse                                                            [@B72]
  miR-106                         Regeneration of NMJ                                                                                                            HDAC4              ALS/mouse                                                            [@B84]
  miR-124                         Neurotransmitter release                                                                                                                          Fruit fly                                                            [@B79]
                                  Neurotransmitter release at the NMJ                                                                                            Rab3a              Slow-channel congenital myasthenic syndrome/mouse                    [@B95]
  miR-125 and let-7               NMJ phenotype, delayed maturation, smaller size, abnormal locomotion, reduced lifespan                                         Abrupt             Fruit fly                                                            [@B12]
  miR-132                         Neuronal morphology and cognition                                                                                              AChE and p250GAP   ALS/mouse                                                            [@B24], [@B74]
                                  Splicing of Tau                                                                                                                PTBP2              Tauopathies/mouse                                                    [@B76], [@B37]
  miR-132, miR-143, and miR-558   Expression is dysregulated in TDP-43 deficient cells. Neurites outgrowth (miR-132)                                                                ALS and FTLD (frontotemporal lobar degeneration)/cell line (mouse)   [@B45]
  miR-133b                        Spinal cord regeneration                                                                                                       RhoA               Zebrafish                                                            [@B91]
  miR-134                         Neuronal development and dendritogenesis                                                                                       Pumilio2           Mouse                                                                [@B28]
  miR-138                         Axonal regeneration                                                                                                            SIRT1              Mouse                                                                [@B55]
  miR-310                         Neurotransmitter release at the NMJ                                                                                            Khc-73             Fruit fly                                                            [@B81]
  miR-338-3p                      Expression is elevated in ALS patients                                                                                                            ALS/human                                                            [@B21]
  miR-431                         Axonal regeneration and outgrowth                                                                                              Kremen1            Mouse                                                                [@B87]
  miR-451                         Dysregulated in immune cells (with many other miRNAs)                                                                                             ALS/mouse                                                            [@B11]

miRNAs are also important for axonal regeneration process in spinal motor neurons. Ablation of Dicer in sciatic nerve of mouse suggested that functional miRNAs are pivotal for nerve regeneration and axonal re-growth ([@B88]). In zebrafish, elevated expression of miR-133b after spinal cord injury represses mRNA translation of RhoA. This process promotes functional recovery of motor neuron axons after traumatic injury ([@B91]). Taken together, we can conclude that miRNAs play a significant role in various processes in motor neurons such as neuronal subtype specification, functional maintenance, and regeneration after injury.

miRNA AT THE NEUROMUSCULAR JUNCTION
===================================

miRNAs are differentially distributed in neuronal compartments such as soma and neurites ([@B49]). Numerous miRNAs are presented in axonal compartment and growth cones in cortical and sympathetic neurons ([@B60]; [@B73]). These data suggests that miRNAs can regulate mRNA translation at the axonal compartments. It seems that miRNAs play a significant role in motor neuron axons, especially at the neuromuscular junction (NMJ). Interestingly, in contrast to vertebrates, *Drosophila* mutant, who lacks one of the most abundant neuronal miRNA, miR-124 did not show any strong defect in neuronal production, differentiation, and NMJ morphology. However, the miR-124 *Drosophila* mutant showed shorter life span, impaired locomotion as well as increased presynaptic neurotransmitter release at the NMJ ([@B79]). Additionally, miR-8 is also reported as an important miRNA for pre-synaptic bouton formation at the *Drosophila* NMJ. Repeated neuronal activity represses the expression of miR-8, and it results in elevated neuronal mRNA translation and synaptic growth ([@B61]). *Drosophila* mutants lacking miR-125 or let-7 expression also showed defects in NMJ phenotypes such as delayed maturation of NMJ, smaller size of NMJ, and abnormality in locomotion. Interestingly, these phenotypes are shown only during metamorphosis ([@B12]). This implies that miRNAs play a specific role for temporal and spatial regulation of gene expression during development. Another interesting miRNA is miR-310. It regulates synaptic homeostasis at the NMJ by regulating translation of kinesin super family member, Khc-73. miR-310 directly represses the translation of Khc-73 to control neurotransmitter release in motor neurons during larval stages ([@B81]). Finally, function of miRNA at mammalian NMJ is described in a mouse model for neuromuscular disease, slow-channel congenital myasthenic syndrome (SCS). Axonal expression of miR-124 is elevated in this model compared to the wild type animals. miR-124 regulates mRNA translation of *Rab3a* in axon in response to amplified Ca^2+^/calpain/cdk5/nitric oxide pathway in muscle cells. In consequence, the elevated expression of miR-124 and reduced expression of Rab3a proteins in nerve terminals decrease neurotransmitter release to the NMJ ([@B95]). Taken together, we can conclude that miRNAs are important players for NMJ formation and function as well as maintaining synaptic homeostasis.

Recently, protein and nucleic acids containing vesicles (exosomes) have been suggested as a new molecular mechanism for communication between cells in nervous system ([@B75]). They can transfer genetic molecules from donor cells to recipient cells, by which they can change physiology of recipient cells ([@B82]). For example, cancer cells release more exosomes than healthy ones. In consequence, it changes physiology of surrounding cells to have more favorable conditions for their metastasis ([@B34]; [@B77]). Moreover, various miRNAs are detected in exosomes released from neurons and muscle cells ([@B29]; [@B30]). These findings strongly suggest that miRNA can function as a signaling molecule for intracellular communication at the NMJ.

TWO COMMON MOTOR NEURON DISEASES; SMA AND ALS
=============================================

PROXIMAL SPINAL MUSCULAR ATROPHY
--------------------------------

Spinal muscular atrophy is a genetically and clinically heterogeneous group of neuromuscular disorders characterized by progressive degeneration of lower alpha motor neurons in the anterior horn of spinal cord ([@B19]). Affected individuals exhibit proximal manifestation of muscle weakness and atrophy. With an incidence of 1:6000 \~ 1:10000 newborns and a carrier frequency of 1:35, proximal SMA is the leading hereditary cause of infant mortality ([@B85]). Due to the highly variable disease severity, four clinical types of SMA are classified based on the age of onset and achieved motor abilities: Type I SMA (Werdnig--Hoffmann), intermediate Type II SMA, mild Type III SMA (Kugelberg--Welander), and Type IV SMA (adult SMA; [@B65]; [@B86]).

Survival of motor neuron 1 (*SMN1*) is the major disease-determining gene of SMA. SMA is caused by homozygous deletion or mutation of *SMN1* ([@B53]). This gene is located on the chromosomal region 5q11.2-13.3 in a segment of \~500 kb, which includes the telomeric *SMN1* and the similar but slightly different centromeric *SMN2*. *SMN2,* which is \>99% identical to *SMN1,* has only a reduced capacity for correct splicing due to a single silent mutation in exon7. *SMN2* produces about 10% of full-length *SMN2* RNA that encodes a protein identical to the one from *SMN1. SMN2*, which can vary from one to six copies per genome, is the main modifier of SMA and influences on SMA severity. The severity of SMA can be affected by various genetic factors ([@B86]). The human SMN protein is a 38 kDa protein, which forms multi-protein complex with its binding partners, seven Gemins (Gemin 2--8). Self-oligomerization of SMN creates the backbone of the complex ([@B7]). SMN is ubiquitously expressed and can be found in the nucleus as well as in the axons and dendrites of neurons ([@B18]; [@B3]). In the nucleus, SMN is localized in subcellular structures called gems, where it interacts with a number of proteins that are essential for RNA processing and splicing ([@B66]). In the axons, SMN interacts with RNA-binding proteins, such as HuD, and plays a role in RNP trafficking for local mRNA translation ([@B3]; [@B27]). SMN also binds to FMRP ([@B67]), KH-type splicing regulatory protein (KSRP; [@B80]) and fused in sarcoma (FUS; [@B90]), which are important for miRNA biogenesis and function.

AMYOTROPHIC LATERAL SCLEROSIS
-----------------------------

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder, which leads to death within 2--3 years of onset. It is one of the most common motor neuron diseases occurring 1.7 \~ 2.3 out of 100,000 person per year in worldwide ([@B8]). The symptom of ALS usually starts after age 50, but it can happen in younger age group. The disease manifests itself by onset of degeneration in specific subset of motor neurons. It progressively spreads to neighboring motor neurons and leads to atrophy of associated muscle tissues ([@B68]). The genetic and environmental causes of ALS is still under investigation, but 90% of them are sporadic or from unknown genetic factors. So far only about 10% of the cases can be traced to genetic factors ([@B4]). The most well known genetic cause of ALS is mutations in or deletion of Cu/Zn Super Oxide Dismutase 1 (*SOD1*; [@B70]). Only recently, with advanced genomic screening tools, several other genes associated with ALS have been identified including TAR DNA-binding protein (*TDP-43*), *FUS*, ALS 2 (*ALS2*), neurofilament heavy peptide (*NEFH*; [@B4]) and C9ORF72 ([@B22]; [@B69]). However, the cellular and pathological mechanisms causing ALS due to mutation or deletion of these genes are still under investigation.

miRNA IN MOTOR NEURON DISEASES
==============================

The role of miRNA and their target genes are intensively studied in cancer field. Studies in cancer cells suggest us that miRNA are involved in many different pathways and their dys-regulation can cause various types of cancers ([@B25]; [@B43]). While the role of individual miRNAs in neurological disorders is not yet fully understood, there are growing evidences that miRNAs play a critical role in neurological disorders, such as miR-206/miR-153 in Alzheimer's disease ([@B52]; [@B54]), miR-34b/miR-9/miR-9^\*^ in Huntington's disease ([@B64]; [@B33]), miR-128a/miR-24/let-7b in mood disorder ([@B94]), miR-189 in Tourette's syndrome ([@B1]), miR-9 in SMA ([@B35]), miR-106/miR-338-3p/miR-451 in ALS ([@B84]; [@B11]; [@B21]), miR-21/miR-431/miR-138 for axonal regeneration for sensory neurons ([@B78]; [@B55]; [@B87]), and miR-133b/miR-21 for spinal cord injury ([@B91]; [@B40]). However, pathological contribution of individual miRNAs to each of these diseases is still under investigation. Especially, our knowledge about the role of miRNAs in motor neuron diseases is very limited. This can be both due to the complexity of the nervous system and the technical difficulties of studying neurological disorders. In this section, we will focus on miRNA related dysregulation in two motor neuron diseases; SMA, and ALS.

miRNA IN SPINAL MUSCULAR ATROPHY PATHOLOGY
------------------------------------------

As it is mentioned above, SMN is a RNA binding protein, which forms a complex with other Gemin proteins, Gemin2-8 ([@B7]). Among the Gemins, Gemin3 and Gemin4 also bind to Ago2, which served the core protein in RISC and plays a role in miRNA biogenesis ([@B58]). Moreover, numerous miRNAs bind to Gemin3 in human and murine neuronal cell lines ([@B23]). From these reports, we can reason that the SMN complex is involved in miRNA biogenesis and/or function. In fact, expression of miRNAs such as miR-9 and miR-9\* were dysregulated in murine embryonic stem cell derived motor neurons harboring a mutation causing SMA ([@B35]). However, cellular mechanisms underlying in SMN mediated miRNA expression and/or function is not yet identified.

Dicer is an RNase playing a role in miRNA biogenesis pathway. The enzyme acts on the stem-loop shape of precursor miRNA (pre-miR) and creates a doubles stranded-miRNAs by cleaving the loop structure off from the pre-miR ([@B9]). It seems that a group of miRNAs get mature by Dicer, while other subset of miRNAs are processed by Ago2 ([@B14]). Thus, deletion of either Dicer or Ago2 protein in cell may lead to severe impairments in miRNA biogenesis and function. In fact, deletion of Dicer in post-mitotic motor neuron causes motor neuron degeneration, similar to the neuromuscular phenotype observed in mouse model for SMA ([@B35]).

miRNA IN AMYOTROPHIC LATERAL SCLEROSIS PATHOLOGY
------------------------------------------------

Dysregulation in miRNA expression and miRNA-related pathways are also reported in ALS. The expression of miR-206, a skeletal muscle specific miRNA, was increased in muscle after denervation of sciatic nerve and its deficiency synergistically worsened disease progress in ALS mouse model harboring a disease causing mutation in superoxide dismutase, *SOD1*. In this study, the elevated expression of miR-206 after denervation promotes reinnervation process at the NMJ via regulating histone deacetylase 4 (*HDAC4*) and fibroblast growth factor (FGF) pathway ([@B84]). This study is the first report suggesting the role of miRNA for nerve regeneration at the NMJ. Recently, additional report showed that the expression of miR-23a, miR-29b, and miR-455 are elevated in skeletal muscle tissues from ALS patients and this may cause dysregulation in mitochondrial gene expression ([@B72]). These findings hint us that dysregulated expression of miRNA in muscle cells significantly contributes to ALS pathology.

Another ALS associated gene, TAR DNA-binding protein-43 (TDP-43) is directly involved in miRNA pathway. TDP-43 is a component of the Dicer and Drosha complexes, which are important for miRNA biogenesis. TDP-43 selectively regulates pri-miRNA processing by binding to primary transcripts of specific miRNAs. It is reported that mutations in *TDP-43* gene causes differential expression of mature and functional miRNAs such as miR-132, miR-143 and miR-558 that in turn contribute to ALS pathology. Interestingly, TDP-43 deficiency caused impairment in neurite outgrowth in Neuro2a cells and it was rescued by over-expressing miR-132 ([@B45]). Additionally, elevated expression of miR-9 is also observed in induced pluripotent stem cell-derived neurons from ALS patient harboring a mutation in *TDP-43* ([@B93]). Together, these data suggest that TDP-43 is required for neuronal differentiation and neurite outgrowth via regulating miRNA biogenesis pathway and their expression.

Mutations in RNA binding protein FUS/TLS (FUS/translocated in liposarcoma) are also found in ALS patients ([@B48]). Similar to TDP-43, FUS/TLS protein binds to pre-mRNA molecules and determines their fate via regulating splicing, transport, stability, and translation ([@B50]). Recently, it has been shown that FUS/TLS promotes biogenesis of specific miRNAs via recruiting Drosha to primary miRNA transcripts. Among them, miRNAs with known function for synaptic plasticity and neuronal development such as miR-132, miR-134, and miR-9 were identified ([@B57]). miR-9 regulates axon growth via direct regulation of microtubule-associated protein 1b (MAP1B) mRNA translation and miR-132 regulates neuronal morphology and growth by targeting various genes including acetylcholinesterase and Tau ([@B24]; [@B76]; [@B20]; [@B37]; [@B74]). miR-134 regulates neuronal development and dendritogenesis in response to neuronal activity ([@B28]). These results suggest that mutations in FUS/TLS may lead to disturbance in miRNA biogenesis and function, which contributes to pathological phenotype observed in ALS patients.

In addition to it, miRNA expression in white blood cells from sporadic ALS patients exhibited distinct expression pattern during disease progress. miRNA profiling data from 14 patients and 14 controls showed that expression of miR-338-3p is increased and expression of seven other miRNAs is decreased in leukocyte from ALS patients ([@B21]). Since bloods are more accessible than motor neurons from patients, this finding suggests that profiling of miRNA expression from bloods can be used as a diagnostic tool for ALS. Taken together, we can conclude that dysregulated miRNA expression contributes to the ALS pathology and profiling of the miRNA expression can serve as a tool for ALS diagnosis.

SUMMARY AND PERSPECTIVE
=======================

With current advanced genetic tools, genetic causes of motor neuron diseases are getting unveiled. However, pathogenesis of motor neuron disease is extremely complex and not yet fully understood. Due to this reason, efficient cure for motor neuron disease is currently unavailable. Interestingly, even though the genetic causes of the diseases are different, their cellular pathomechanisms share common traits; miRNA biogenesis and expression. Here, we reviewed current knowledge about the role of miRNA in two common motor neuron diseases, SMA and ALS. Dysregulated miRNA expression in neuromuscular system may lead to neurodegeneration and disease pathology. However, the question, how individual miRNAs contribute to development and maintenance of the NMJ and how their dysregulation may cause ALS or SMA, requires further investigation.
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